Zentalis Pharmaceuticals (ZNTL) PT Raised to $50 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Price: $3.56 --0%
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $50.00 (from $49.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Zentalis Pharmaceuticals launches public stock offering
- High Liner Foods Inc. (HLF:CN) (HLNFF) PT Raised to Cdn$17.50 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
